Evista

Evista (Raloxifene Hydrochloride) is a medication used to treat and prevent osteoporosis in postmenopausal women. It belongs to a class of drugs known as selective estrogen receptor modulators (SERMs).

Evista is primarily used to prevent and treat osteoporosis in postmenopausal women. It works by mimicking the effects of estrogen on bone, helping to maintain bone density and reduce the risk of fractures. Evista is also sometimes used to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis or at high risk for the disease. What is Evista used for? It is used for managing bone health and reducing certain cancer risks in specific patient groups.

Common effects of Evista may include hot flashes, leg cramps, and swelling in the legs. Some users might experience flu-like symptoms, joint pain, or sweating. These effects vary among individuals and are not experienced by everyone who takes the medication.

Evista should be used with caution in individuals with a history of blood clots or those at risk for blood clots. It is important to discuss your medical history with a healthcare provider before starting Evista. Regular monitoring may be required to ensure the medication is working as intended.

Evista may interact with certain medications, including cholesterol-lowering drugs and some antibiotics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare provider.